Feinstein Institutes receives $2.9M NIH grant for IVF genetic risk factors studies
MANHASSET, N.Y.--(BUSINESS WIRE)--Genetic testing and selection of embryos generated from in vitro fertilization (IVF) have given rise to the controversial “designer baby” debate. Recently, the use of a new technology called polygenic embryo selection (PES) has developed to identify the risk for complex diseases of adulthood. To further study the accuracy – and the ethics – of PES, researchers at The Feinstein Institutes for Medical Research have been awarded a $2.9 million grant from the Natio ...
